These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26743033)

  • 21. A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor.
    Niesen J; Hehmann-Titt G; Woitok M; Fendel R; Barth S; Fischer R; Stein C
    Cancer Lett; 2016 May; 374(2):229-40. PubMed ID: 26912070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fcgamma receptor 1 (CD64), a target beyond cancer.
    Thepen T; Huhn M; Melmer G; Tur MK; Barth S
    Curr Pharm Des; 2009; 15(23):2712-8. PubMed ID: 19689341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of IRF1 and IFN-β interaction on the M1 polarization of macrophages and its antitumor function.
    Xie C; Liu C; Wu B; Lin Y; Ma T; Xiong H; Wang Q; Li Z; Ma C; Tu Z
    Int J Mol Med; 2016 Jul; 38(1):148-60. PubMed ID: 27176664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophages modulate the viability and growth of human mesenchymal stem cells.
    Freytes DO; Kang JW; Marcos-Campos I; Vunjak-Novakovic G
    J Cell Biochem; 2013 Jan; 114(1):220-9. PubMed ID: 22903635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A human Fc gamma RI/CD64 transgenic model for in vivo analysis of (bispecific) antibody therapeutics.
    Heijnen IA; Van de Winkel JG
    J Hematother; 1995 Oct; 4(5):351-6. PubMed ID: 8581368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases.
    Akinrinmade OA; Chetty S; Daramola AK; Islam MU; Thepen T; Barth S
    Biomedicines; 2017 Sep; 5(3):. PubMed ID: 28895912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Regulatory effects of polyporus polysaccharide on the expressions of cytokines released from M1 macrophages].
    Jiang Z; Huang R; Zhang X; Hu J; Zhao J; Zeng X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1030-3. PubMed ID: 25270203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophages and cutaneous inflammation.
    McCormick TS; Stevens SR; Kang K
    Nat Biotechnol; 2000 Jan; 18(1):25-6. PubMed ID: 10625384
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum of patients with Behçet's disease induces classical (pro-inflammatory) activation of human macrophages in vitro.
    Alpsoy E; Kodelja V; Goerdt S; Orfanos CE; Zouboulis ChC
    Dermatology; 2003; 206(3):225-32. PubMed ID: 12673080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small cleavable adapters enhance the specific cytotoxicity of a humanized immunotoxin directed against CD64-positive cells.
    Hetzel C; Bachran C; Fischer R; Fuchs H; Barth S; Stöcker M
    J Immunother; 2008 May; 31(4):370-6. PubMed ID: 18391759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages.
    Van den Bossche J; Baardman J; Otto NA; van der Velden S; Neele AE; van den Berg SM; Luque-Martin R; Chen HJ; Boshuizen MC; Ahmed M; Hoeksema MA; de Vos AF; de Winther MP
    Cell Rep; 2016 Oct; 17(3):684-696. PubMed ID: 27732846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pro-apoptotic effect of an anti-CD37 scFv-Fc fusion protein, in combination with the anti-CD20 antibody, ofatumumab, on tumour cells from B-cell malignancies.
    Smolewski P; Robak P; Cebula-Obrzut B; Misiewicz M; Mędra A; Majchrzak A; Witkowska M; Stromatt S; Robak T
    Eur J Cancer; 2014 Oct; 50(15):2677-84. PubMed ID: 25154027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection of scFv Antibody Fragments Binding to Human Blood versus Lymphatic Endothelial Surface Antigens by Direct Cell Phage Display.
    Keller T; Kalt R; Raab I; Schachner H; Mayrhofer C; Kerjaschki D; Hantusch B
    PLoS One; 2015; 10(5):e0127169. PubMed ID: 25993332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor efficacy of the scFv-based fusion protein and its enediyne-energized analogue directed against epidermal growth factor receptor.
    Sheng W; Shang Y; Miao Q; Li Y; Zhen Y
    Anticancer Drugs; 2012 Apr; 23(4):406-16. PubMed ID: 22205154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin affects the features of a human hepatocellular cell line (HepG2) by regulating macrophage polarization in a co-culture microenviroment.
    Chen M; Zhang J; Hu F; Liu S; Zhou Z
    Diabetes Metab Res Rev; 2015 Nov; 31(8):781-9. PubMed ID: 26467463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Fully Human Agonistic Single Chain Fragment Variable Antibody Targeting Death Receptor 5 with Potent Antitumor Activity In Vitro and In Vivo.
    Lei G; Xu M; Xu Z; Gu L; Lu C; Bai Z; Wang Y; Zhang Y; Hu H; Jiang Y; Zhao W; Tan S
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28953230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human MAP Tau Based Targeted Cytolytic Fusion Proteins.
    Akinrinmade OA; Jordaan S; Hristodorov D; Mladenov R; Mungra N; Chetty S; Barth S
    Biomedicines; 2017 Jun; 5(3):. PubMed ID: 28653985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inclusion of a furin-sensitive spacer enhances the cytotoxicity of ribotoxin restrictocin containing recombinant single-chain immunotoxins.
    Goyal A; Batra JK
    Biochem J; 2000 Jan; 345 Pt 2(Pt 2):247-54. PubMed ID: 10620501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactive oxygen species in the tumor niche triggers altered activation of macrophages and immunosuppression: Role of fluoxetine.
    Ghosh S; Mukherjee S; Choudhury S; Gupta P; Adhikary A; Baral R; Chattopadhyay S
    Cell Signal; 2015 Jul; 27(7):1398-412. PubMed ID: 25819340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elimination of different leukaemia subtypes using novel CD89-specific human cytolytic fusion proteins.
    Gresch G; Schenke L; Mladenov R; Zwirner S; Cremer C; Niesen J; Grieger E; Brümmendorf T; Jost E; Fischer R; Stockmeyer B; Barth S; Nachreiner T; Stein C
    Br J Haematol; 2018 Oct; 183(2):313-317. PubMed ID: 29048126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.